We are live on
!
Find out more
LSC
Lyon Street Capital Portfolio holdings
AUM
$67M
This Fund
S&P 500
This Quarter
Est. Return
+21.27%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$300M
AUM Growth
+$40.5M
(+16%)
Cap. Flow
+$2.32M
Cap. Flow
% of AUM
0.77%
Top 10 Holdings %
Top 10 Hldgs %
46.35%
Holding
64
New
9
Increased
20
Reduced
13
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BFYT
Benefytt Technologies, Inc. Class A Common Stock
BFYT
|
+$11.5M |
| 2 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$10.5M |
| 3 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
+$6.19M |
| 4 |
Ligand Pharmaceuticals
LGND
|
+$5.52M |
| 5 |
NEOS
Neos Therapeutics, Inc
NEOS
|
+$5.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STMP
Stamps.com, Inc.
STMP
|
+$5.42M |
| 2 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
+$5.21M |
| 3 |
Herbalife
HLF
|
+$5.05M |
| 4 |
eHealth
EHTH
|
+$4.59M |
| 5 |
Axogen
AXGN
|
+$4.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.34% |
| 2 | Technology | 18.99% |
| 3 | Financials | 14.84% |
| 4 | Communication Services | 9.98% |
| 5 | Industrials | 5.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTEM
51
DELISTED
Molecular Templates, Inc.
MTEM
| $557K | 0.19% |
+3,708
| New | +$465K |
|
|
TNAV
52
DELISTED
Telenav Inc.
TNAV
| $502K | 0.17% |
91,274
-405,464
| -82% | -$2.26M |
|
53
Digital Turbine
APPS
$1.15B
| $306K | 0.1% |
+170,800
| New | +$281K |
|
|
54
Axogen
AXGN
$2.46B
| – | – |
-213,749
| Closed | -$4.14M |
|
|
55
eHealth
EHTH
$43.8M
| – | – |
-192,275
| Closed | -$4.59M |
|
56
Lumentum
LITE
$66.1B
| – | – |
-71,922
| Closed | -$3.91M |
|
57
Stride
LRN
$3.41B
| – | – |
-196,053
| Closed | -$3.5M |
|
58
Supernus Pharmaceuticals
SUPN
$2.67B
| – | – |
-55,047
| Closed | -$2.2M |
|
59
Western Digital
WDC
$189B
| – | – |
-51,843
| Closed | -$3.39M |
|
|
CUTR
60
DELISTED
Cutera, Inc.
CUTR
| – | – |
-83,506
| Closed | -$3.45M |
|
|
GLUU
61
DELISTED
Glu Mobile Inc.
GLUU
| – | – |
-918,739
| Closed | -$3.45M |
|
|
MEET
62
DELISTED
The Meet Group, Inc. Common Stock
MEET
| – | – |
-960,329
| Closed | -$3.5M |
|
|
EFII
63
DELISTED
Electronics for Imaging
EFII
| – | – |
-45,582
| Closed | -$1.95M |
|
|
STMP
64
DELISTED
Stamps.com, Inc.
STMP
| – | – |
-26,760
| Closed | -$5.42M |
|
Similar funds
DCM
SCMU
TLCM
EA
A
AAI
EM
ALFA
Lyon Street Capital's Q4 2017 Portfolio in Review
As of Q4 2017, Lyon Street Capital held 64 positions worth $300M, up 16% from $259M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lyon Street Capital's Q4 2017 filing shows 9 new, 20 increased, 13 reduced and 11 closed positions. Its largest new stake was Ligand Pharmaceuticals: 63,729 shares worth $5.44M. The largest sale was Stamps.com, Inc., an estimated $5.42M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 23% a quarter earlier, followed by Technology and Financials.
- Lyon Street Capital's largest Q4 2017 buy was Ligand Pharmaceuticals: 63,729 shares worth $5.44M.
- Lyon Street Capital added most to Benefytt Technologies, Inc. Class A Common Stock in Q4 2017, an estimated $11.5M increase.
- Lyon Street Capital's biggest Q4 2017 reduction was Concert Pharmaceuticals, Inc., cutting an estimated $5.21M.
- Lyon Street Capital fully exited Stamps.com, Inc. in Q4 2017, selling an estimated $5.42M.
- Lyon Street Capital's ten largest holdings make up 46% of its $300M portfolio in Q4 2017.
- Lyon Street Capital opened 9 new positions and closed 11 in Q4 2017.
- Lyon Street Capital's portfolio value rose 16% quarter-over-quarter to $300M.
Based on Lyon Street Capital's 13F filing for Q4 2017, filed 14 Feb 2018.